Is there any place for resistant starch, as alimentary prebiotic, for patients with type 2 diabetes?

Gargari BP 1 , Namazi N 2 , Khalili M 3 , Sarmadi B 4 , Jafarabadi MA 5 , Dehghan P 6

Affiliations 

  • 1 Department of biochemistry & Nutrition, Faculty of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran
  • 2 Faculty of Nutrition, Nutrition Research Center, Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
  • 3 Neurosciences Research Center Tabriz University of Medical Sciences, Tabriz, Iran
  • 4 Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences, University Putra Malaysia, 43400 Serdang, Selangor, Malaysia
  • 5 Traffic Injury Prevention Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  • 6 Faculty of Nutrition, Nutrition Research Center, Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: [email protected]
Complement Ther Med, 2015 Dec;23(6):810-5.
PMID: 26645521 DOI: 10.1016/j.ctim.2015.09.005

Abstract

The aim of the present study was to determine effects of Resistant Starch (RS2) on metabolic parameters and inflammation in women with type 2 diabetes (T2DM).

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications